Hypocretin (orexin) cell loss in Parkinson's disease

By Thannickal Thomas C.  

Brain, Vol. 130, Iss. 6, 2007-06 ,pp. : 1586-1595

Oxford University Press

Access to resources Recommend Favorite

Narcolepsy: a neurodegenerative disease of the hypocretin/orexin system?

By Kilduff T.S.  

Trends in Neurosciences, Vol. 23, Iss. 11, 2000-11 ,pp. : 512-512

Elsevier

Access to resources Recommend Favorite

Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia

By Compta Yaroslau   Santamaria Joan   Ratti Luca   Tolosa Eduardo   Iranzo Alex   Muoz Esteban   Valldeoriola Francesc   Casamitjana Roser   Ros Jose   Marti Maria J.  

Brain, Vol. 132, Iss. 12, 2009-12 ,pp. : 3308-3317

Oxford University Press

Access to resources Recommend Favorite

The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders

By Kilduff T.S.   Peyron C.  

Trends in Neurosciences, Vol. 23, Iss. 8, 2000-08 ,pp. : 359-365

Elsevier

Access to resources Recommend Favorite

Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1)

By Baier Paul Christian  

Brain, Vol. 131, Iss. 10, 2008-10 ,pp. : 2734-2741

Oxford University Press

Access to resources Recommend Favorite